Status:
UNKNOWN
Adjuvants With Intrathecal Bupivacaine for Postoperative Analgesia
Lead Sponsor:
Assiut University
Conditions:
Postoperative Pain
Eligibility:
All Genders
18-60 years
Phase:
PHASE4
Brief Summary
The aim of this study is to compare the postoperative analgesic effect of intrathecal dexmedetomidine combined with bupivacaine and midazolam combined with bupivacaine in high tibial osteotomy.
Detailed Description
With more than 80% of patients experiencing acute pain following surgical procedures, and half of them reporting inadequate pain therapy, the control and management of post-surgical pain remains one o...
Eligibility Criteria
Inclusion
- Adult patients aged 18-60 years.
- Gender: Both males and females.
- Scheduled patients for High tibial osteotomy under spinal anesthesia.
- American Society of Anesthesiologists (ASA) physical status: I and II
Exclusion
- Patient refusal
- Allergy to the studied drugs.
- Patients with contraindications to spinal anesthesia.
- Patients with advanced decompensated cardiac, respiratory,renal or hepatic diseases
- Coagulopathy or thrombocytopenia
- CNS diseases as epilepsy, stroke or psychiatric illness.
Key Trial Info
Start Date :
November 1 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 30 2024
Estimated Enrollment :
90 Patients enrolled
Trial Details
Trial ID
NCT06082232
Start Date
November 1 2023
End Date
December 30 2024
Last Update
October 16 2023
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.